查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2152214

自動乳房超音波市場規模、佔有率和趨勢分析報告：按產品、最終用途、地區和細分市場分類（2026-2033 年）

Automated Breast Ultrasound Market Size, Share & Trends Analysis Report By Product (Automated Breast Volume Scanner, Automated Breast Ultrasound), By End Use (Hospitals, Diagnostic Imaging Laboratories), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

全球自動乳腺超音波市場預計到 2025 年將擴大到 73 億美元，2026 年至 2033 年的複合年成長率為 15.2%。

北美市場佔據主導地位，預計2025年將佔全球銷售額的35.0%。久坐不動的生活方式、肥胖、飲食習慣的改變以及飲酒量的增加，導致乳癌發生率上升，預計將增加患病風險。此外，對早期乳房病變可靠識別的需求日益成長，促使主要製造商致力於開發自動化診斷方法。其他各項政府主導的措施和宣傳活動也對市場成長做出了顯著貢獻。

根據美國癌症協會的報告，預計到2025年，全球將有約204萬人被診斷出罹患癌症。此外，世界衛生組織於2025年2月發布的報告指出，2024年全球確診的乳癌病例約320萬例，死亡人數約110萬人。乳癌病例的增加凸顯了對技術先進的醫療設備的迫切需求，這些設備能夠比傳統方法更便捷、更早地檢測出癌症。預計這項需求將在預測期內推動市場成長。

乳癌早期診斷的存活率顯著較高，但如果發現時已是晚期，存活率則會降至25%左右。根據麻省理工學院（MIT）2023年7月發表的一篇報導，該校研究人員開發了一種穿戴式式超音波設備，能夠早期檢測腫瘤。預計此類技術進步將在未來幾年進一步加速市場成長。

政府機構和企業採取的各項措施提高了男性和女性對乳癌的認知，從而對市場成長產生了積極影響。例如，世界衛生組織（世衛組織）宣布了一項新的藍圖，旨在2040年將乳癌死亡人數減少250萬人。同樣，印度衛生和家庭福利部透過「綜合計畫」、「國家援助基金」和「衛生部委任撥款」等項目，生活水準。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：自動化乳房超音波市場：變數、趨勢和範圍

  • 市場概況及未來展望
  • 市場規模和成長前景
  • 市場動態
  • 自動化乳房超音波市場分析工具

第4章：自動化乳房超音波市場：產品具體估算與趨勢分析

  • 自動化乳房超音波市場：產品特定趨勢分析，2025 年和 2033 年
  • 自動乳房容積掃描儀
  • 自動乳房超音波（ABUS）

第5章：自動化乳房超音波市場：依最終用途分類的估算與趨勢分析

  • 自動乳房超音波市場：按最終用途分類的趨勢分析，2025 年和 2033 年
  • 醫院
  • 診斷影像檢查實驗室
  • 其他

第6章：自動化乳房超音波市場：區域估算與趨勢分析

  • 2025 年及 2033 年自動化乳房超音波市場區域佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • GE HealthCare.
    • Koninklijke Philips NV
    • Siemens Healthcare Private Limited
    • CANON MEDICAL SYSTEMS CORPORATION
    • TELEMED Medical Systems srl
    • Hologic, Inc.
    • SuperSonic Imagine
    • Lunit Inc.
    • Delphinus Medical Technologies, Inc.
簡介目錄
Product Code: GVR-4-68038-013-2

The global automated breast ultrasound market size was valued at USD 2.4 billion in 2025 and is projected to grow from USD 2.7 billion in 2026 to USD 7.3 billion by 2033, at a CAGR of 15.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. The increasing prevalence of breast cancer owing to a rise in sedentary lifestyles, obesity, changes in eating habits, and rising alcohol consumption is expected to increase the risk of the disease. In addition, the demand for reliable identification of breast lesions in the early stage of cancer is encouraging major manufacturing companies to develop automated diagnosis methods. Furthermore, various other government initiatives and awareness programs are significant contributors to the growth of the market.

According to a report from the American Cancer Society, approximately 2.04 million people were diagnosed with cancer in 2025. In addition, a report published by the WHO in February 2025 noted about 3.2 million cases of breast cancer and 1.1 million deaths worldwide in 2024. The increase in breast cancer cases highlights the need for technologically advanced medical devices that facilitate easier and earlier detection compared to conventional methods. This demand is expected to drive growth in the market over the forecast period.

The survival rate for breast cancer is significantly higher when diagnosed in the early stages; however, it drops to around 25 percent when detected at later stages. An article from the Massachusetts Institute of Technology, published in July 2023, reported that MIT researchers have designed a wearable ultrasound device capable of detecting tumors at an early stage. Such technological advancements are likely to boost market growth further in the coming years.

Various initiatives by government institutions and companies have raised awareness about breast cancer among both men and women, positively impacting market growth. For example, the WHO launched a new roadmap for breast cancer to save 2.5 million lives from the disease by 2040. Similarly, the Ministry of Health and Family Welfare in India is providing financial assistance to individuals living below the poverty line who are suffering from diseases such as cancer through the Umbrella Scheme, Rashtriya Arogya Nidhi, and the Health Minister's Discretionary Grant.

Automated Breast Ultrasound Market Report Segmentation

This report forecasts revenue growth at global; regional; and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global automated breast ultrasound market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)

Automated Breast Volume Scanner

Automated Breast Ultrasound (ABUS)

  • End Use Outlook (Revenue, USD Million, 2021 - 2033)

Hospital

Diagnostics Imaging Laboratories

Others

  • Regional Outlook (Revenue, USD Million, 2021 - 2033)

North America

    • U.S.
    • Canada
    • Mexico

Europe

    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Asia Pacific

    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand

Latin America

    • Brazil
    • Argentina

MEA

    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Automated Breast Ultrasound Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Automated Breast Ultrasound Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Automated Breast Ultrasound Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Automated Breast Ultrasound Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Automated Breast Volume Scanner
    • 4.3.1. Automated Breast Volume Scanner Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Automated Breast Ultrasound (ABUS)
    • 4.4.1. Automated Breast Ultrasound (ABUS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Automated Breast Ultrasound Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Automated Breast Ultrasound Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Diagnostics Imaging Laboratories
    • 5.4.1. Diagnostics Imaging Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Automated Breast Ultrasound Market: Regional Estimates & Trend Analysis

  • 6.1. Automated Breast Ultrasound Market Share, By Region, 2025 & 2033 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Sweden Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Automated Breast Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. GE HealthCare.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Koninklijke Philips N.V.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Siemens Healthcare Private Limited
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. CANON MEDICAL SYSTEMS CORPORATION
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. TELEMED Medical Systems srl
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Hologic, Inc.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. SuperSonic Imagine
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Lunit Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Delphinus Medical Technologies, Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives